Keywords: gsk, initiates, phase, iii, trials, key, drug

GSK initiates Phase III trials of key drug using Flamel's Micropump

Article | 27 September 2004

Print This

Flamel Technologies of France says that UK drug major GlaxoSmithKline has initiated Phase III clinical trials of one of its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in